The homozygous deletion of SMARCB1 is a hallmark of poorly differentiated chordoma (101), but this finding suggests that even partial inactivation of SMARCB1 in conventional chordoma could be used as a prognostic biomarker. This evidence concerns the gene SMARCB1 and chordoma.